Moderna Therapeutics, the most highly valued private company in biotech, has run into troubling safety problems with its most ambitious therapy, STAT has learned — and is now banking on a mysterious new technology to keep afloat its brash promise of reinventing modern medicine.”

Damian Garde. Moderna Hits Safety Problems in Bold Bid to Reinvent Medicine. Stat, 10 January 2017.